Namandjé Bumpus, FDA's Deputy Commissioner, Resigns Amid Leadership Changes

Namandjé Bumpus, the Food and Drug Administration’s principal deputy commissioner, officially announced her decision to leave the agency at the end of the year, a move communicated by FDA Commissioner Robert Califf in an email to staff[1][2]. Bumpus took on the role of principal deputy commissioner in February 2024, following her tenure as the FDA's chief scientist, during which she made significant contributions to the agency's reorganization and modernization efforts[1][2]. Her departure comes along with other structural changes in the agency's leadership, notably marked by the upcoming retirement of Doug Throckmorton, the deputy center director for regulatory programs[1]. Bumpus expressed her gratitude for her time at the FDA, while her future plans and her successor remain unannounced[2].